Cargando…
Inhibition of HIF-1α by Atorvastatin During (131)I-RTX Therapy in Burkitt’s Lymphoma Model
Backgrounds: Radioimmunotherapy (RIT) serves as a targeted therapy for non-Hodgkin lymphomas (NHL). Although HIF(Hypoxia-inducible factors)-1α is an important biomarker during radiation therapy, its role in NHL is unclear. Atorvastatin (ATV) is used as a combination drug for chemotherapy. Methods: W...
Autores principales: | Kim, Eun-Ho, Ko, Hae Young, Yu, A Ram, Kim, Hyeongi, Zaheer, Javeria, Kang, Hyun Ji, Lim, Young-Cheol, Cho, Kyung Deuk, Joo, Hyun-Yoo, Kang, Min Kyoung, Lee, Jae Jun, Lee, Seung-Sook, Kang, Hye Jin, Lim, Sang Moo, Kim, Jin Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281655/ https://www.ncbi.nlm.nih.gov/pubmed/32403237 http://dx.doi.org/10.3390/cancers12051203 |
Ejemplares similares
-
Combination Radioimmunotherapy Strategies for Solid Tumors
por: Zaheer, Javeria, et al.
Publicado: (2019) -
Comparison between Fractionated Dose and Single Dose of Cu-64 Trastuzumab Therapy in the NCI-N87 Gastric Cancer Mouse Model
por: Zaheer, Javeria, et al.
Publicado: (2019) -
PET Tracing of Biodistribution for Orally Administered (64)Cu-Labeled Polystyrene in Mice
por: Im, Changkeun, et al.
Publicado: (2022) -
Correlation of ACE2 with RAS components after Losartan treatment in light of COVID-19
por: Zaheer, Javeria, et al.
Publicado: (2021) -
Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect
por: Lee, Seonhwa, et al.
Publicado: (2019)